In China, following a significant (12.7%) rise in 2019, avermectin market in terms of volume declined slightly (-0.6%), reaching 3,488 tons in 2020, according to StrategyHelix.
This 2nd edition of Avermectin Market in China includes following information:
Market Overview: Production, Capacity, Grow Rate, CAGR
Competitors: Qilu Pharmaceutical Co., Ltd., Ningxia Taiyicin Biotech Co., Ltd., Hebei Xingbai Pharmaceutical Group Co., Ltd., Hebei Veyong Bio-Chemical Co., Ltd., Daqing Jefene Bio-Chemical Co., Ltd., Others
Years Considered: this database covers the period 2010-2020
After you have placed your order and your payment has been authorized, the database download link will be emailed to you instantly. Please note that the database is supplied in an Excel spreadsheet.
StrategyHelix’ data is protected by copyright and cannot be supplied to any third party.
StrategyHelix DataPass produces a series of directories and databases on industries, economies and consumers in Western and Central Europe, North and South America, Asia Pacific, the Middle East and Africa. DataPass aims at helping our clients analyze market context and identify future trends.